Education
About Us
Working with TipRanks
Follow Us
Keymed Biosciences, Inc. (HK:2162)
:2162
RESEARCH TOOLSreports
Comparison Results
Keymed Biosciences, Inc.
HK$66.15
HK$19.13B
―
97.76%
0 Buy
0 Hold
0 Sell
Moderate Buy
Simcere Pharmaceutical Group Limited
HK$12.48
HK$31.58B
40.34
136.36%
1 Buy
0 Hold
0 Sell
Moderate Buy
CARsgen Therapeutics Holdings Ltd.
HK$20.08
HK$12.15B
―
404.52%
0 Buy
0 Hold
1 Sell
Moderate Sell
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$24.58
HK$10.64B
281.69
297.09%
0 Buy
0 Hold
0 Sell
Hold
Performance Comparison
HK:2162
Keymed Biosciences, Inc.
66.15
32.50
96.58%
HK:1672
Ascletis Pharma, Inc.
11.91
11.03
1253.41%
HK:2096
Simcere Pharmaceutical Group Limited
12.48
7.20
136.36%
HK:2157
Lepu Biopharma Co. Ltd. Class H
9.38
6.33
207.54%
HK:2171
CARsgen Therapeutics Holdings Ltd.
20.08
16.14
409.64%
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
24.58
18.37
295.81%